Gastrointestinal Toleration of Inulin Products
Effect of Two Doses of Inulin Products on Gastrointestinal Tolerance
1 other identifier
interventional
26
1 country
1
Brief Summary
The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 grams of inulin products should be well tolerated and not result in a significant increase in gastrointestinal symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Aug 2008
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 12, 2009
CompletedFirst Posted
Study publicly available on registry
August 13, 2009
CompletedFebruary 10, 2017
February 1, 2017
2 months
August 12, 2009
February 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastrointestinal Tolerance Score
Aug 2008 thru Oct 2008
Study Arms (1)
inulin
EXPERIMENTAL0, 5, 10 g inulin
Interventions
Orange juice fortified with 0, 5g, and 10g of 2 inulin products
Eligibility Criteria
You may qualify if:
- english speaking
- healthy men and women
- and 60 years of age
- non-smoking
- non-dieting
- BMI less than 30
- standard diet consisting of no more than 15 grams fiber
- not taking medications
You may not qualify if:
- BMI more than 30
- CVD
- Diabetes Mellitus
- cancer in prior 5 years
- renal or hepatic disease
- bacterial infection in past 2 weeks
- more than 5 kg weight loss in past 3 months
- history of drug or alcohol abuse in past 6 months
- use of weight loss, lipid-lowering, anti-hypertensive, or anti- inflammatory medications
- concurrent or recent intervention study participation
- consumption of laxatives
- history of gastrointestinal disorders
- food allergies
- pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- Cargillcollaborator
Study Sites (1)
University of Minnesota: Nutrition and Food Science Department
Minneapolis, Minnesota, 55108, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Joanne L Slavin, PhD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2009
First Posted
August 13, 2009
Study Start
August 1, 2008
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
February 10, 2017
Record last verified: 2017-02